Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group

Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial

(2015) Peter Hillmen et al.   LANCET

Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations†

(2014) L. Decoster et al.   ANNALS OF ONCOLOGY

Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials

(2014) V. Goede et al.   HAEMATOLOGICA

Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model

(2014) T. Baumann et al.   HAEMATOLOGICA

International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With Cancer

(2014) Hans Wildiers et al.   JOURNAL OF CLINICAL ONCOLOGY

The relevance of a geriatric assessment for elderly patients with a haematological malignancy – A systematic review

(2014) M.E. Hamaker et al.   LEUKEMIA RESEARCH

Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions

(2014) Valentin Goede et al.   NEW ENGLAND JOURNAL OF MEDICINE

Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia

(2014) Richard R. Furman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial

(2013) Susan O'Brien et al.   LANCET ONCOLOGY

Improved targeting of cancer care for older patients: A systematic review of the utility of comprehensive geriatric assessment

(2013) Aliya Ramjaun et al.   Journal of Geriatric Oncology

Use of Geriatric Assessment for Older Adults in the Oncology Setting: A Systematic Review

(2012) M. T. E. Puts et al.   JNCI-Journal of the National Cancer Institute

The Value of Geriatric Assessments in Predicting Treatment Tolerance and All-Cause Mortality in Older Patients With Cancer

(2012) Marije E. Hamaker et al.   ONCOLOGIST

Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score

(2011) Martine Extermann et al.   CANCER

Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study

(2011) Arti Hurria et al.   JOURNAL OF CLINICAL ONCOLOGY

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

(2010) M Hallek et al.   LANCET

First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

(2009) B. F. Eichhorst et al.   BLOOD

Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia

(2009) Wolfgang U. Knauf et al.   JOURNAL OF CLINICAL ONCOLOGY

A Manual of Guidelines to Score the Modified Cumulative Illness Rating Scale and Its Validation in Acute Hospitalized Elderly Patients

(2008) Fabio Salvi et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY